2022 BRFSS Survey Results: North Carolina

Other Tobacco Use

Before today, have you heard of heated tobacco products?

View results for a demographic group:
Select a different topic:
View results for a different geographical area:
  Total
Respond.^
Yes No
N % C.I.(95%) N % C.I.(95%)
TOTAL 3,511 503 14.6 13.1-16.1 3,008 85.4 83.9-86.9
GENDER
Male 1,612 290 18.5 16.2-21.0 1,322 81.5 79.0-83.8
Female 1,899 213 11.0 9.3-13.0 1,686 89.0 87.0-90.7
Have Health Insurance
Yes 3,142 458 14.8 13.3-16.5 2,684 85.2 83.5-86.7
No 320 35 11.7 7.9-17.1 285 88.3 82.9-92.1
Body Mass Index
Underweight 46 *** *** *** *** *** ***
Recommended Range 896 119 14.0 11.2-17.4 777 86.0 82.6-88.8
Overweight 1,161 180 15.5 13.0-18.3 981 84.5 81.7-87.0
Obese 1,098 157 15.0 12.5-17.9 941 85.0 82.1-87.5
Current Smoker
Yes 458 102 21.8 17.2-27.2 356 78.2 72.8-82.8
No 3,021 398 13.4 11.9-15.0 2,623 86.6 85.0-88.1
History of CVD**
Yes 392 57 13.4 9.2-19.0 335 86.6 81.0-90.8
No 3,089 445 14.9 13.3-16.5 2,644 85.1 83.5-86.7
Binge Drinker
Yes 498 108 22.2 17.9-27.2 390 77.8 72.8-82.1
No 2,840 377 13.3 11.8-15.0 2,463 86.7 85.0-88.2
Heavy Drinker
Yes 206 41 18.1 12.4-25.6 165 81.9 74.4-87.6
No 3,142 441 14.5 12.9-16.1 2,701 85.5 83.9-87.1
COPD
Yes 290 46 14.1 9.5-20.5 244 85.9 79.5-90.5
No 3,214 457 14.7 13.2-16.3 2,757 85.3 83.7-86.8
Current Asthma
Yes 318 47 19.3 13.9-26.2 271 80.7 73.8-86.1
No 3,176 454 14.2 12.7-15.8 2,722 85.8 84.2-87.3
Diabetes
Yes 503 68 15.9 11.9-20.9 435 84.1 79.1-88.1
No 3,000 434 14.5 12.9-16.1 2,566 85.5 83.9-87.1
Functional Disability
Yes 1,142 167 14.9 12.3-17.9 975 85.1 82.1-87.7
No 2,334 333 14.5 12.8-16.4 2,001 85.5 83.6-87.2
Has two or more chronic diseases†
Yes 1,094 167 16.6 13.7-19.9 927 83.4 80.1-86.3
No 2,417 336 13.7 12.1-15.5 2,081 86.3 84.5-87.9

Back to Other Tobacco Use.

**History of cardiovascular disease includes history of heart attack or coronary heart disease or stroke.

†Chronic diseases include heart disease (heart attack/stoke/angina), current asthma, skin cancer, other cancer, COPD, arthritis, depression, kidney disease and diabetes.

PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2022 are NOT comparable to 2010
and earlier years.

***The estimate was suppressed because it did not meet statistical reliability standards. See BRFSS 2022 Annual Results Technical Notes for more details.

^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.

BRFSS Home | Annual Questionnaires | Technical Notes

This page was generated on 14DEC23.

SCHS Home | FAQs | Contacts